Posted in | News | Nanomaterials

Nanomaterial Global Sales Expected to Reach Over $34 Billion by 2025

Reportlinker.com announces that a new market research report is available in its catalogue: World Nanomaterials Market.

Global nanomaterial demand to rise 20% annually through 2013

While market demand has not matched the considerable hype that nanotechnology has generated over the past decade and a half, nanomaterials have managed to attain an appreciable commercial presence. Global nanomaterials demand will to continue to rise, posting robust twenty percent annual gains to $3.6 billion in 2013. By 2025, nanomaterials are expected to reach over $34 billion in sales, having still only scratched the surface of their immense market potential.

Carbon nanotubes to gain market share through 2025

Many of the initial uses for nanomaterials, which have had the greatest commercial impact, have involved relatively low-tech materials and applications. These include nanoscale versions of conventional materials, including silica, alumina, titanium dioxide, clays, and metals such gold and silver. These nanomaterials have found widespread applications as wafer polishing slurries for semiconductor processing, personal care products such as sunscreen, and antibacterial treatments for consumer products. In the next decade or two, however, some of the relatively novel nanomaterials, particularly carbon nanotubes, will account for a larger share of overall nanomaterial demand. Producers such as Arkema, Bayer, Nanocyl and Showa Denko have raised or announced capacity increases for nanotubes in recent years, as these products find more use in electronics and motor vehicle components.

Health care to surpass electronics as largest world market for nanomaterials

Health care was the second largest market for nanomaterials in 2008, but is expected to overtake electronics as the leading outlet in 2013 and beyond. Nanomaterial-based pharmaceuticals, which include nanoscale drug delivery systems as well as nanosized drug active ingredients, have enjoyed a significant degree of commercial success to date. In the future, it is expected that nanomaterials will expand from pharmaceuticals into other medical product and health care applications, including diagnostics, imaging and dental care. Additionally, the range of nanomaterials used will broaden, encompassing nanotubes, nanoscale metals and new materials such as dendrimers and quantum dots.

US to remain largest market

In 2008, the nanomaterial market was overwhelmingly concentrated in the developed world. The US and Japan combined to account for over half of world demand, while Western Europe and two high-income Asian nations, Taiwan and South Korea, represented an additional 34 percent. While virtually all nanomaterial markets will experience robust double-digit gains in demand, the fastest gains are forecast in the rapidly industrializing countries of China and India. By 2025, it is expected that China will overtake Japan as the second-largest market for nanomaterials in the world behind the United States.

Technical, environmental issues exist for nanomaterials

While the outlook for nanomaterials is generally bright, a number of potential complications exist. In some instances, technical issues such as agglomeration of nanotubes in plastic composites are still a challenge. Perhaps more fundamentally, concerns about the safety and environmental effect of nanomaterials may be impediments to commercial success.

Study coverage

This new industry study presents historical demand data (2003, 2008) plus forecasts for 2013, 2018 and 2025 by material, market, world region and for 15 countries. The study also considers market environment factors, evaluates company market share and profiles industry competitors worldwide.

Source: http://www.reportlinker.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.